Global Infertility Treatment Devices Patent Landscape Report 2024

Global Infertility Treatment Devices Market Size

The global infertility treatment devices market was valued at USD 1.22 billion in 2023. It is expected to grow at a CAGR of 8.3% during the forecast period of 2024-2032 and attain a market value of USD 2.50 billion by 2032.

The market value is driven by the rising infertility rates globally. The growing technological advancements such as modern infertility treatment devices are becoming highly efficient, leading to an increased number of patent applications. 

Patent Landscape Report Coverage

The Global Infertility Treatment Devices Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for infertility treatment devices include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with infertility treatment devices. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within infertility treatment device technologies.

Key Inclusions

• Patent Valuation Analysis

An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for infertility treatment devices technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with infertility treatment devices.

• Analysis of Patent Applications

A comprehensive summary of several patent applications which were filed across different jurisdictions for infertility treatment devices and their relative value are covered. The analysis will cover the capital in terms of innovation and type.

• Analysis of Granted Patents

Detailed analysis of the granted patents across different jurisdictions for infertility treatment devices and their relative value in the IP are covered in the final report.

Infertility Treatment Devices Patent Outlook

• The need for infertility treatment devices is being driven by rising rates of infertility brought on by delayed childbearing, changes in lifestyle, and environmental factors.

• The patent applications associated with infertility treatment devices are increasing, driven by technological advancements in assisted reproductive technologies (ART), like advanced imaging systems, IVF equipment, and ICSI devices.

• More couples are seeking medical assistance due to increased awareness of and social acceptance of infertility treatments, which is driving up demand for treatment devices.

What are Infertility Treatment Devices?

Infertility treatment devices  are specialized medical equipment using technologies intended to help identify, treat, and manage infertility in both men and women. They are essential in assisting single people and couples to have healthy pregnancies.

The components of infertility treatment devices include sperm analyzer systems, ovum aspiration pumps, sperm separation devices, micromanipulator systems, imaging systems, incubators, microscopes, cryo-systems, and others. Sperm analyzer systems measure parameters like count, motility, morphology, and concentration to evaluate the quality and functionality of sperm assisted with advanced imaging and computer-assisted technology. These systems help with the diagnosis and treatment of male infertility by providing accurate and unbiased data.

Infertility Treatment Devices Industry Growth Drivers

Technological Advancement is Expected to Boost the Patent Industry Growth

The accuracy and success rates of fertility treatment is being improved by technological developments in infertility treatment equipment, such as the creation of sophisticated IVF incubators and time-lapse imaging systems. The market growth is driven by these innovations, which offer less invasive and more effective options for diagnosing and treating infertility. For instance, Merck released two cutting-edge reproductive technologies, namely, the GeriTM medium and the GaviTM oocyte protocol. Both products contribute to the improvement of important phases in assisted reproductive therapy (ART), an area in which laboratory technologies are essential to the efficacy of treatment.

There is an increase in patent activity, focused on enhancing the performance of infertility treatment devices. In 2022, there were 420 patents granted while in 2023, the number increased to 493 patents. Patents covering these technologies are crucial for companies and thus impacting the infertility treatment devices patent landscape significantly.

Advances in Cryopreservation Techniques is Expected to Propel Infertility Treatment Devices Patent Industry

The market is also growing because of the advancements in gamete and embryo cryopreservation techniques that increase the efficacy and success rates of reproductive therapies.

Infertility Treatment Devices Patent Segmentation

The report will cover the following sections in detail:

Analysis by Type

• Sperm Analyzer Systems

• Ovum Aspiration Pumps

• Sperm Separation Devices

• Micromanipulator Systems

• Imaging Systems

• Incubators

• Microscopes

• Cryo-systems

• Others

Analysis by Procedure Type

• Assisted Reproductive Technology

• Artificial Insemination

• Fertility Surgery

• Others

Infertility Treatment Devices Patent Segmentation Analysis

The breakup based on type includes sperm analyzer systems, ovum aspiration pumps, sperm separation devices, micromanipulator systems, imaging systems, incubators, microscopes, cryo-systems, and others. Ovum aspiration pumps are used during assisted reproductive techniques like in vitro fertilization (IVF), where mature eggs are extracted from the ovaries. These pumps minimize damage and increase the likelihood of successful fertilization by providing controlled suction for safe and efficient egg collection.

Infertility Treatment Devices Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for infertility treatment device patents. The region has around 20,000+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.

Patent Profile of Key Companies

Among the players with infertility treatment devices patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the infertility treatment devices field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Genentech Inc

Based in South San Francisco, California, Genentech Inc. is a well-known biotechnology business that specializes in creating cutting-edge medical treatments, such as devices for treating infertility. They use genetic engineering and state-of-the-art research to develop advanced treatments for a range of illnesses, including reproductive health.

Other companies include Vertex Pharma, Guangzhou Shanshan Medical Apparatus & Instrument Industry Co Ltd, Fertility Basics Inc, Merck Sharp & Dohme, Abbvie INC, Ucb Biopharma Sprl, Amgen INC, Bristol Myers Squibb Co, Lilly Co Eli, Novartis AG, Abbott, Pfizer Inc, Theravance Biopharma R&d Ip LLC, Takeda Pharmaceuticals Co, among others.

Reasons to Purchase this Report

The Infertility Treatment Devices Patent Report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and makes it understandable which companies have important patents in this field of Infertility Treatment Devices.

• Innovation Insights: The patent analysis reveals new innovations and technologies in Infertility Treatment Devices.

• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry within the infertility treatment device patent landscape.

• Risk Assessment: In technology-intensive fields such as infertility treatment devices, risks of IP infringement are common. Analyzing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

Key Questions Answered in the Infertility Treatment Devices Patent Landscape Report 

• Who are the key players in the infertility treatment devices patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in infertility treatment device patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in the infertility treatment devices industry?
• How do patent strategies impact competitive advantage?
• What are the implications of patent filings in infertility treatment devices?
• What are the challenges and opportunities in the infertility treatment devices patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in infertility treatment devices?

Related Reports

Infertility Treatment Devices Market

Infertility Drugs Market

Infertility Diagnostics Devices Market